🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Confederación Americana de Urología (CAU) y UroTeragLATAM juntos para promover la educación PSMA en LATAM. Era JORNADA: “EL FUTURO CON PSMA” ✔️ GRATIS ✔️ MULTIDISCIPLINARIO 👇👇👇 Daniel Castellano Diego Barreiro Federico Ferraris Declan Murphy Mauricio Fernandez L Danny Mena - nuclear medicine

STAMPEDE2 now up and running. Patient reported outcomes are key to sucessful trials and current tools may not reflect patient needs and issues. As part of our QOL programme for STAMPEDE2 we have reviewed this with our patient representatives. sciencedirect.com/science/articl…

📝Editorial #btsm Current challenges in the treatment of gliomas: The molecular era Castalia Fernández, MD. Zafra-Martín J, Felipe Couñago PhD wjgnet.com/2218-4333/full…

8 Gy single fx liver RT + BSC improves liver pain control compared to BSC in painful hepatic cancer: the CCTG HE1 trial thelancet.com/journals/lanon…

Extremely important trial comparing SBRT and RP out in European Urology . Congrats to Nicholas van As and team!

Interesting efficacy signal for bladder preservation (TMT) + nivolumab. Increased #bladdercancer free survival & OS va TMT No new safety issue. Additional data expected from GETUG Bladder Sparing study. Larger trials needed. #ESMO2024

Pleased to share the newest MARCAP publication, out in European Urology -- the TRANSPORT analysis of T recovery after ADT for localized PCa, led by Wee Loon Ong and Tahmineh Romero Free share link: authors.elsevier.com/a/1joOX14kplyz…

ICPO Theranostics Virtual Summit 2024!! Regístrate con CÓDIGO PROMOCIONAL exclusivo para la comunidad UroTeragLATAM Para conocer el código promocional del 60% de descuento, revisa tu email o suscríbete al newsletter en uroteraglatam.com 👇👇👇 ICPO Foundation

Feliz por 🚀 Lanzamiento oficial del estudio clínico iniciado por el investigador en #NMIBC en UroTarget Argentina 🇦🇷!! PI: Dr. VILLOLDO Gustavo Villoldo SubI: FLoscoMD Martín Angel Gracias blatam uro y MSD LatAm por el apoyo!

See you there! InterOncology Education & Prevention

¡¡¡Gran kickoff!! Primera reunión de #AAOCDigital... Inteligencia artificial y salud digital en #Oncología Gracias Asociación Argentina de Oncología Clínica (AAOC) Por el espacio y a todos los miembros José Máximo Barros, MD 🇦🇷 FLoscoMD Pablo CASTRO PEÑA Pablo Companys Andrea Marchioni Enrique Diaz Canton Román Oberti

🎙 Randomized Trial 🚨: SBRT vs. RFA for Recurrent Small HCC—Is It Time to Rethink Local Treatment? OncoAlert 🔬 Study Highlights: 📌 Phase III trial, 166 👥 with recurrent HCC (≤5 cm, single lesion). 📌 Randomized to RFA (n=83) or SBRT (n=83) Key Outcomes: ✅ Local

👏 nueva sub comisión Asociación Argentina de Oncología Clínica (AAOC) ..... siempre innovando #SaludDigital 🤳 #IA 🖥️ FLoscoMD Andrea Marchioni Enrique Diaz Canton Diego Enrico José Máximo Barros, MD 🇦🇷 Pablo CASTRO PEÑA Pablo Companys Claudio Martin

📢🚨 Hot off the press The Lancet Oncology for #kidneycancer! shorturl.at/kAGVd. SABR vs thermal ablation; - Despite ⏫age, ⏬worse GFR, and ⏫tumours for SABR - SABR ⬆️effective than TA (at 1, 2 and 5 yrs) - esp for RCC >4cm - same renal decline (p=0.75) - similar F/U #radonc

Mañana reanudamos sesiones de la sociedad de radiocirugía de LATAM e ibérica #ALAIR les esperamos!! revisando temas desde una perspectiva multidisciplinaria basada en casos clínicos #SRS #SBRT #radiosurgery us02web.zoom.us/meeting/regist… vmx444haT0qYsoXiiN6AJg

🔔📣📢 RADIOSA full paper is finally out! Read our publication now online on The Lancet Oncology! Randomised trial in the metachronous oligomets hormone-sensitive PCa setting reporting improved clinical PFS with the combination of SBRT and a short course of ADT!

Does the ADT destroy micromets or simply delay progression? Luca Valle and I share our thoughts thelancet.com/journals/lanon… Again congrats to the authors on this important trial.

No crossover No SBRT Are you kidding me?

It’s today! #AsociacionLatinoamericanaeIbericadeRadiocirugía (#ALAIR)

FDA approval today for 177Lu-PSMA-617 in taxane-naive mCRPC fda.gov/drugs/resource… UroToday.com Georgia Cancer Center